Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice

Agbor-Enoh, 2009, Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice, Antimicrob. Agents Chemother., 53, 1727, 10.1128/AAC.00729-08 Andrews, 2014, Drug repurposing and human parasitic protozoan diseases, Int. J. Parasitol.: Drugs Drug Resist, 4, 95 Andrews, 2012, Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors, PloS One, 7, 10.1371/journal.pone.0031847 Andrews, 2012, Towards histone deacetylase inhibitors as new antimalarial drugs, Curr. Pharmaceut. Des., 18, 3467 Andrews, 2009, Targeting histone deacetylase inhibitors for anti-malarial therapy, Curr. Top. Med. Chem., 9, 292, 10.2174/156802609788085313 Andrews, 2000, Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents, Int. J. Parasitol., 30, 761, 10.1016/S0020-7519(00)00043-6 Bechtsi, 2017, Genomics and epigenetics of sexual commitment in Plasmodium, Int. J. Parasitol., 47, 425, 10.1016/j.ijpara.2017.03.002 Benkert, 2011, Toward the estimation of the absolute quality of individual protein structure models, Bioinformatics, 27, 343, 10.1093/bioinformatics/btq662 Bertelsen, 2003, Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine, Drug Metab. Dispos., 31, 289, 10.1124/dmd.31.3.289 Bozdech, 2003, The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum, PLoS Biol., 1, E5, 10.1371/journal.pbio.0000005 Burrows, 2017, New developments in anti-malarial target candidate and product profiles, Malar. J., 16, 26, 10.1186/s12936-016-1675-x Chaal, 2010, Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle, PLoS Pathog., 6, 10.1371/journal.ppat.1000737 Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. D Biol. Crystallogr., 66, 12, 10.1107/S0907444909042073 Chen, 2017, Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways, PloS One, 12 Cheng, 2016, Preclinical pharmacokinetics study of R- and S-enantiomers of the histone deacetylase inhibitor, AR-42 (NSC 731438), in rodents, AAPS J., 18, 737, 10.1208/s12248-016-9876-3 Chua, 2017, Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth, Int. J. Parasitol.: Drugs and Drug Resistance, 7, 42 2017 2017 Coetzee, 2020, Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites, Sci. Rep., 10, 2355, 10.1038/s41598-020-59298-4 Coleman, 2014, A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion, Cell Host Microbe, 16, 177, 10.1016/j.chom.2014.06.014 Darkin-Rattray, 1996, Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase, Proc. Natl. Acad. Sci. U.S.A., 93, 13143, 10.1073/pnas.93.23.13143 Dow, 2008, Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors, Antimicrob. Agents Chemother., 52, 3467, 10.1128/AAC.00439-08 Duraisingh, 2005, Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum, Cell, 121, 13, 10.1016/j.cell.2005.01.036 Engel, 2015, Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites, Int. J. Parasitol.: Drugs and Drug Resistance, 5, 117 Floyd, 1992, Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones, J. Med. Chem., 35, 756, 10.1021/jm00082a018 Freitas-Junior, 2005, Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites, Cell, 121, 25, 10.1016/j.cell.2005.01.037 Huber, 1993, A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites, Acta Trop., 55, 257, 10.1016/0001-706X(93)90083-N Kanyal, 2018, Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum, FEBS J., 285, 1767, 10.1111/febs.14376 Kuperman, 2001, Drug Metab. Dispos., 29, 1403 Lopez-Rubio, 2007, 5' flanking region of var genes nucleate histone modification patterns linked to phenotypic inheritance of virulence traits in malaria parasites, Mol. Microbiol., 66, 1296, 10.1111/j.1365-2958.2007.06009.x Lu, 2005, Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors, J. Med. Chem., 48, 5530, 10.1021/jm0503749 Lu, 2004, Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors, J. Med. Chem., 47, 467, 10.1021/jm0303655 Maestro, 2020, vols. vols. 2020–3 Malmquist, 2012, Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum, Proc. Natl. Acad. Sci. U.S.A., 109, 16708, 10.1073/pnas.1205414109 Melesina, 2015, Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors, J. Mol. Graph. Model., 62, 342, 10.1016/j.jmgm.2015.10.006 Miao, 2006, The malaria parasite Plasmodium falciparum histones: Organization, expression, and acetylation, Gene, 369, 53, 10.1016/j.gene.2005.10.022 Müller, 2004, Redox and antioxidant systems of the malaria parasite Plasmodium falciparum, Mol. Microbiol., 53, 1291, 10.1111/j.1365-2958.2004.04257.x Ndifor, 1990, Cytochrome P-450 activity in malarial parasites and its possible relationship to chloroquine resistance, Mol. Biochem. Parasitol., 41, 251, 10.1016/0166-6851(90)90188-R Ontoria, 2016, Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs, ACS Med. Chem. Lett., 7, 454, 10.1021/acsmedchemlett.5b00468 Phillips, 2017, Malaria, Nat Rev Dis Primers, 3, 17050, 10.1038/nrdp.2017.50 Potluri, 2020, Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria, Malar. J., 19, 365, 10.1186/s12936-020-03421-3 Saul, 1997, Evidence of cross-contamination among laboratory lines of Plasmodium berghei, Mol. Biochem. Parasitol., 84, 143, 10.1016/S0166-6851(96)02779-X Sborov, 2017, A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas, Leuk. Lymphoma, 58, 2310, 10.1080/10428194.2017.1298751 Sumanadasa, 2012, Antimalarial activity of the anticancer histone deacetylase inhibitor SB939, Antimicrob. Agents Chemother., 56, 3849, 10.1128/AAC.00030-12 Tng, 2020, Achiral derivatives of hydroxamate AR-42 potently inhibit class I HDAC enzymes and cancer cell proliferation, J. Med. Chem., 63, 5956, 10.1021/acs.jmedchem.0c00230 Trenholme, 2014, Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules, Antimicrob. Agents Chemother., 58, 3666, 10.1128/AAC.02721-13 Valencia, 2016, A phase 1 study of AR-42 in patients with advanced solid tumors, including nervous system tumors, J. Clin. Oncol., 34, 10.1200/JCO.2016.34.15_suppl.2558 Vanheer, 2020, Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages, Antimicrob. Agents Chemother., 64, 10.1128/AAC.02523-19 World Health Organization, 2020